Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]

Bibliographic Details
Main Authors: Fatma Merve Tepetam, MD, Şeyma Özden, MD, Fatma Kübra Kılıç, MD, Cihan Örçen, MD, Tuğçe Yakut, MD
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123001229
_version_ 1827355966362877952
author Fatma Merve Tepetam, MD
Şeyma Özden, MD
Fatma Kübra Kılıç, MD
Cihan Örçen, MD
Tuğçe Yakut, MD
author_facet Fatma Merve Tepetam, MD
Şeyma Özden, MD
Fatma Kübra Kılıç, MD
Cihan Örçen, MD
Tuğçe Yakut, MD
author_sort Fatma Merve Tepetam, MD
collection DOAJ
first_indexed 2024-03-08T04:51:00Z
format Article
id doaj.art-cfe8e5013c1945fe82bd2c350781974d
institution Directory Open Access Journal
issn 1939-4551
language English
last_indexed 2024-03-08T04:51:00Z
publishDate 2024-02-01
publisher Elsevier
record_format Article
series World Allergy Organization Journal
spelling doaj.art-cfe8e5013c1945fe82bd2c350781974d2024-02-08T05:07:33ZengElsevierWorld Allergy Organization Journal1939-45512024-02-01172100861Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]Fatma Merve Tepetam, MD0Şeyma Özden, MD1Fatma Kübra Kılıç, MD2Cihan Örçen, MD3Tuğçe Yakut, MD4University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, Turkey; Corresponding author. University of Health Sciences, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Basibuyuk Mahallesi, Maltepe, 34854, Istanbul, Turkey.University of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Immunology and Allergy, Istanbul, TurkeyUniversity of Health Sciences, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Pulmonology, Istanbul, TurkeyUniversity of Health Sciences, Derince Training and Research Hospital, Kocaeli, TurkeyUniversity of Health Sciences, Diyarbakır Gazi Yasargil Training and Research Hospital, Diyarbakır, Turkeyhttp://www.sciencedirect.com/science/article/pii/S1939455123001229
spellingShingle Fatma Merve Tepetam, MD
Şeyma Özden, MD
Fatma Kübra Kılıç, MD
Cihan Örçen, MD
Tuğçe Yakut, MD
Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
World Allergy Organization Journal
title Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
title_full Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
title_fullStr Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
title_full_unstemmed Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
title_short Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
title_sort erratum to does nsaid exacerbated respiratory disease n erd accompanying severe asthma affect biological treatment response efficacy of omalizumab and mepolizumab in n erd world allergy organ 2023 100817
url http://www.sciencedirect.com/science/article/pii/S1939455123001229
work_keys_str_mv AT fatmamervetepetammd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817
AT seymaozdenmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817
AT fatmakubrakılıcmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817
AT cihanorcenmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817
AT tugceyakutmd erratumtodoesnsaidexacerbatedrespiratorydiseasenerdaccompanyingsevereasthmaaffectbiologicaltreatmentresponseefficacyofomalizumabandmepolizumabinnerdworldallergyorgan2023100817